Abstract
An emerging theme in neurodegenerative diseases is the aggregation of proteins as inclusions in neural cells. Their presence is a useful tool in the differential diagnosis of the particular illness, although in no instance is the specific role of the inclusions in disease pathogenesis understood at present. However, apart from their role in the disease mechanism, the inclusions themselves may contain important molecular clues as to the mechanism(s) behind the specific inclusion-associated disease. Thus, isolation and analysis of the composition of the inclusions is likely to yield biochemical evidence of the cellular pathways that are involved in the disease process.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ross, C. A. and Poirier, M. A. (2004) Protein aggregation and neurodegenerative disease.Nat. Med. 10 Suppl, S10–17.
Ozawa, T. (2006) Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum.Acta Neuropathol. (Berl) 112, 531–538.
Olanow, C. W. and McNaught, K. S. (2006) Ubiquitin-proteasome system and Parkinson7#x0027;s disease.Mov. Disord. 21, 1806–1823.
Lee, H. G., Petersen, R. B., Zhu, X., Honda, K., Aliev, G., Smith, M. A., and Perry, G. (2003) Will preventing protein aggregates live up to its promise as prophylaxis against neurodegen-erative diseases?Brain Pathol. 13, 630–638.
Slow, E. J., Graham, R. K., Osmand, A. P., Devon, R. S., Lu, G., Deng, Y., Pearson, J., Vaid, K., Bissada, N., Wetzel, R., Leavitt, B. R., and Hayden, M. R. (2005) Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.Proc. Natl. Acad. Sci. USA 102, 11402–11407.
Iwatsubo, T., Yamaguchi, H., Fujimuro, M., Yokosawa, H., Ihara, Y., Trojanowski, J. Q., and Lee, V. M. (1996) Lewy bodies: purification from diffuse Lewy body disease brains.Ann. NY. Acad. Sci. 786, 195–205.
Iwatsubo, T., Yamaguchi, H., Fujimuro, M., Yokosawa, H., Ihara, Y., Trojanowski, J. Q., and Lee, V. M. (1996) Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease.Am. J. Pathol. 148, 1517–1529.
Hazeki, N., Tsukamoto, T., Yazawa, I., Koyama, M., Hattori, S., Someki, I., Iwatsubo, T., Nakamura, K., Goto, J., and Kanazawa, I. (2002) Ultrastructure of nuclear aggregates formed by expressing an expanded polyglutamine.Biochem. Biophys. Res. Commun. 294, 429–440.
Iwahashi, C. K., Yasui, D. H., An, H. J., Greco, C. M., Tassone, F., Nannen, K., Babineau, B., Lebrilla, C. B., Hagerman, R. J., and Hagerman, P. J. (2006) Protein composition of the intranuclear inclusions of FXTAS.Brain 129, 256–271.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press
About this protocol
Cite this protocol
Iwahashi, C., Hagerman, P.J. (2008). Isolation of Pathology-Associated Intranuclear Inclusions. In: Hancock, R. (eds) The Nucleus. Methods in Molecular Biology, vol 463. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-406-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-59745-406-3_13
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-977-2
Online ISBN: 978-1-59745-406-3
eBook Packages: Springer Protocols